Takeda and Degron enter molecular glue degrader partnership worth over $1.2bn
PMLiVE
by Emily Kimber
4d ago
The companies will focus on targets in oncology, neuroscience and inflammation ..read more
Visit website
Agenda announced for FlyPharma Vienna 2024
PMLiVE
by FlyPharma Conferences
4d ago
The conference will take place on 23 to 24 October at Vienna AirportCity ..read more
Visit website
Merck KGaA signs definitive agreement to acquire Mirus Bio in deal worth $600m
PMLiVE
by Jen Brogan
4d ago
The deal aims to advance Merck’s viral vector manufacturing of cell and gene therapies ..read more
Visit website
Bristol Myers Squibb unveils ten-year strategy to improve access to medicines in LMICs
PMLiVE
by Emily Kimber
4d ago
The company has collaborated with the ATOM Coalition to make Opdivo available in select countries ..read more
Visit website
Eli Lilly shares positive late-stage results for mirikizumab in Crohn’s disease
PMLiVE
by Emily Kimber
4d ago
Nearly one in every 100 people in the US are diagnosed with inflammatory bowel disease ..read more
Visit website
Consolidation in healthcare marketing
PMLiVE
by Emily Kimber
4d ago
By Tony Walford ..read more
Visit website
Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition
PMLiVE
by Jen Brogan
5d ago
The company will gain access to HI-Bio’s lead asset for immune-mediated and rare diseases ..read more
Visit website
Eli Lilly and Aktis enter $1bn partnership to develop anticancer radiopharmaceuticals
PMLiVE
by Jen Brogan
5d ago
Lilly will gain rights to develop Aktis’ lead programme targeting a tumour-associated antigen ..read more
Visit website
Johnson & Johnson shares positive phase 3 results for Tremfya versus Stelara in Crohn’s disease
PMLiVE
by Jen Brogan
5d ago
The GALAXI programme comprises three trials evaluating the IL-23 inhibitor in the IBD condition ..read more
Visit website
LifeArc and King’s College London partner to accelerate treatment for motor neurone disease
PMLiVE
by Jen Brogan
5d ago
The rare neurodegenerative disease affects one in every 300 people in the UK ..read more
Visit website

Follow PMLiVE on FeedSpot

Continue with Google
Continue with Apple
OR